Exact Mass: 715.2417342
Exact Mass Matches: 715.2417342
Found 45 metabolites which its exact mass value is equals to given mass value 715.2417342,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
(1R,2S,3S,4S,5S,6R,7R,9S,10R)-2,6-diacetoxy-1,9-dibenzoyloxy-3-nicotinoyloxy-4-hydroxydihydro-beta-agarofuran
C39H41NO12 (715.2628626000001)
(1R,2S,3S,4S,5R,7S,8S,9R,10R)-2,3-diacetoxy-8,9-dibenzoyloxy-1-nicotinoyloxy-4-hydroxydihydro-beta-agarofuran
C39H41NO12 (715.2628626000001)
(1R,2S,3S,4S,5R,7S,8S,9R,10R)-2,8-diacetoxy-3,9-dibenzoyloxy-1-nicotinoyloxy-4-hydroxydihydro-beta-agarofuran
C39H41NO12 (715.2628626000001)
acetonitrile,cyclohexa-1,3-dien-1-yl-[(4R,5R)-5-[hydroxy(diphenyl)methyl]-2,2-dimethyl-1,3-dioxolan-4-yl]-phenylmethanol,dichlorotitanium,1,2-dimethoxyethane
C37H43Cl2NO6Ti (715.1946747999999)
9-[3-(4,6-Diphenyl-1,3,5-triazin-2-yl)phenyl]-9-phenyl-3,3-dicarbazole
(2S)-2-[[(4S)-4-[[(4S)-4-[[4-[(6aR)-3-amino-1-oxo-2,5,6,6a,7,9-hexahydroimidazo[1,5-f]pteridin-8-yl]benzoyl]amino]-4-carboxybutanoyl]amino]-4-carboxybutanoyl]amino]pentanedioic acid
alpha-Neup5Ac-(2->6)-beta-D-GalpNAc-(1->4)-beta-D-GlcpNAc
beta-Decafluoro-meso-decamethylcalix[5]pyrrole
C35H35F10N5 (715.2732629999999)
alpha-Neup5Ac-(2->6)-beta-D-GlcpNAc-(1->4)-D-GlcpNAc
alpha-Neup5Ac-(2->3)-beta-D-GalpNAc-(1->4)-beta-D-GlcpNAc
9-deoxy-9-acetamido-alpha-N-acetylneuraminyl-(2->6)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosamine
[2-tert-butyl-4-[(E,3E)-3-[3-(3-carboxypropyl)-3-methyl-5-sulfo-1-(3-sulfopropyl)indol-2-ylidene]prop-1-enyl]chromen-7-ylidene]-diethylazanium
C36H47N2O9S2+ (715.2722832000001)
[4-tert-butyl-2-[(E,3E)-3-[3-(3-carboxypropyl)-3-methyl-5-sulfo-1-(3-sulfopropyl)indol-2-ylidene]prop-1-enyl]chromen-7-ylidene]-diethylazanium
C36H47N2O9S2+ (715.2722832000001)
Ifenprodil (tartrate)
C21H27NO2.1/2C4H6O6 (715.2206058)
Ifenprodil tartrate is a typical noncompetitive NMDA receptor antagonist. Ifenprodil tartrate exerts high affinity at NR1A/NR2B receptors (IC50=0.34 μM) over 400-fold than at NR1A/NR2A receptors (IC50=146 μM)[1]. Ifenprodil tartrate inhibits GIRK (Kir3), reduces inward currents through the basal GIRK activity. Ifenprodil tartrate has the potential to be a cerebral vasodilator[2]. Ifenprodil tartrate is a typical noncompetitive NMDA receptor antagonist. Ifenprodil tartrate exerts high affinity at NR1A/NR2B receptors (IC50=0.34 μM) over 400-fold than at NR1A/NR2A receptors (IC50=146 μM)[1]. Ifenprodil tartrate inhibits GIRK (Kir3), reduces inward currents through the basal GIRK activity. Ifenprodil tartrate has the potential to be a cerebral vasodilator[2].
5,12,14-tris(acetyloxy)-10-[3-(acetyloxy)phenyl]-19-azahexacyclo[20.2.2.1⁸,¹⁹.0²,⁷.0¹⁰,¹⁸.0¹¹,¹⁶]heptacosa-1(25),2,4,6,8(27),11,13,15,22(26),23-decaen-24-yl acetate
methyl (1r,2r,4s)-4-{[(2r,4s,5r,6s)-5-{[(2s,4s,5s,6s)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-4-(dimethylamino)-6-methyloxan-2-yl]oxy}-2-ethyl-2,5,7,12-tetrahydroxy-6,11-dioxo-3,4-dihydro-1h-tetracene-1-carboxylate
6-{[4,5-bis(acetyloxy)-2-[(5-hydroxy-6-{[4-hydroxy-2-(1-hydroxyethyl)pyrrolidin-3-yl]oxy}-2-(hydroxymethyl)-4-methoxyoxan-3-yl)oxy]oxan-3-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid
13-[(4,5-dihydroxy-3-methoxy-4,6-dimethyloxan-2-yl)oxy]-23-(dimethylamino)-11,15,22,24-tetrahydroxy-12-methoxy-1,11-dimethyl-20,25-dioxahexacyclo[19.3.1.0²,¹⁹.0⁵,¹⁸.0⁷,¹⁶.0⁹,¹⁴]pentacosa-2(19),3,5(18),7,9(14),15-hexaene-6,17-dione
4,12-bis(acetyloxy)-5,7-bis(benzoyloxy)-2-hydroxy-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-3-yl pyridine-3-carboxylate
C39H41NO12 (715.2628626000001)
methyl 4-({5-[(4,5-dihydroxy-6-methyloxan-2-yl)oxy]-4-(dimethylamino)-6-methyloxan-2-yl}oxy)-2-ethyl-2,5,7,10-tetrahydroxy-6,11-dioxo-3,4-dihydro-1h-tetracene-1-carboxylate
(2s)-2-{[hydroxy({2-hydroxy-4-[4-(2-hydroxy-4-methoxy-6-methylbenzoyloxy)-2-methyl-6-{[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}benzoyloxy]-6-methylphenyl})methylidene]amino}propanoic acid
C34H37NO16 (715.2112242000001)
2-{[hydroxy({2-hydroxy-4-[4-(2-hydroxy-4-methoxy-6-methylbenzoyloxy)-2-methyl-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}benzoyloxy]-6-methylphenyl})methylidene]amino}propanoic acid
C34H37NO16 (715.2112242000001)
methyl (1r,2r,4s)-4-{[(2r,4s,5s,6s)-5-{[(2s,4s,5s,6s)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-4-(dimethylamino)-6-methyloxan-2-yl]oxy}-2-ethyl-2,5,7,10-tetrahydroxy-6,11-dioxo-3,4-dihydro-1h-tetracene-1-carboxylate
(2s,3s,4s,5r,6s)-6-{[(2r,3r,4s,5s)-4,5-bis(acetyloxy)-2-{[(2r,3r,4r,5r,6s)-5-hydroxy-6-{[(2r,3r,4s)-4-hydroxy-2-[(1r)-1-hydroxyethyl]pyrrolidin-3-yl]oxy}-2-(hydroxymethyl)-4-methoxyoxan-3-yl]oxy}oxan-3-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid
(1s,11r,12r,13r,21s,22s,23r,24s)-13-[(4,5-dihydroxy-3-methoxy-4,6-dimethyloxan-2-yl)oxy]-23-(dimethylamino)-11,15,22,24-tetrahydroxy-12-methoxy-1,11-dimethyl-20,25-dioxahexacyclo[19.3.1.0²,¹⁹.0⁵,¹⁸.0⁷,¹⁶.0⁹,¹⁴]pentacosa-2(19),3,5(18),7,9(14),15-hexaene-6,17-dione
methyl (1r,4s)-4-({5-[(4,5-dihydroxy-6-methyloxan-2-yl)oxy]-4-(dimethylamino)-6-methyloxan-2-yl}oxy)-2-ethyl-2,5,7,10-tetrahydroxy-6,11-dioxo-3,4-dihydro-1h-tetracene-1-carboxylate
methyl (1r,2s,4s)-4-({5-[(4,5-dihydroxy-6-methyloxan-2-yl)oxy]-4-(dimethylamino)-6-methyloxan-2-yl}oxy)-2-ethyl-2,5,7,10-tetrahydroxy-6,11-dioxo-3,4-dihydro-1h-tetracene-1-carboxylate
(1s,2s,3s,4s,5r,6r,7s,9r,12r)-4,12-bis(acetyloxy)-5,7-bis(benzoyloxy)-2-hydroxy-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-3-yl pyridine-3-carboxylate
C39H41NO12 (715.2628626000001)